Progressive Multifocal Leukoencephalopathy (PML) is a fatal demyelinating disease of the central nervous system (CNS) affecting patients with immunosuppressive disorders, especially those infected with the human immunodeficiency virus type 1 (HIV-1). The human neurotropic polyomavirus, JCV is the established etiologic agent of this disease which has the ability to productively infect and destroy oligodendrocytes, a subclass of glial cells that is responsible for production of myelin proteins and myelin sheaths in brain. The unique ability of JCV to replicate in oligodendrocytes rests on the activation of viral early gene transcription by a series of regulatory proteins present in glial cells. The product of the viral early gene, T-antigen, along with glial regulatory proteins, ensure subsequent events during the lytic cycle which include transcription of the viral late genes and replication to ensure subsequent events during the lytic cycle which include transcription of the viral late genes and replication of viral DNA. In addition to demyelination of white matter, histologic analysis of PML brain has revealed several morphological abnormalities including the appearance of enlarged oligodendrocytes with loss of normal chromatin, the presence of giant, bizarre astroyctes with pleiomorphic nuclei and mitotic figures in areas with no evidence for active viral replication. These observations suggest that expression of the viral early protein, T-evidence for active viral replication. These observations suggest that expression of the viral early protein, T-antigen, in the absence of lytic infection, may interfere with hot regulatory mechanisms, such as cell cycle circuitry pathways, to induce morphological alterations which are seen in pathological specimens of PML brain. In support of this concept, results from transgenic mice have indicated that expression of the JCV early protein, T-antigen, by a transgene containing the sequence for only the viral early genes induces dysmyelination of the CNS and several histological abnormalities similar to those seen in PML brain. According to our earlier results, the association of JCV T-antigen with myelin gene regulatory proteins and functional inactivation of these proteins may be responsible for the reduced levels of myelin gene expression in the brains of experimental animals. As such, in this research project we propose to: 1) investigate the molecular pathway whereby the JCV early protein, T-antigen, in the absence of viral lytic infection, may affect oligodendrocyte and astrocyte cell function; and 2) determine the molecular mechanism by which the JCV early protein, T-antigen, through its association with regulatory proteins orchestrates viral gene expression and replication during lytic infection of glial cells. Such comprehensive studies of viral host interaction at the molecular level should enable us to understand the molecular pathogenesis of viral-induced CNS disorders and provide us with critical information and biological regents for therapeutic intervention.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Program Projects (P01)
Project #
5P01NS030916-09
Application #
6353134
Study Section
Special Emphasis Panel (ZNS1)
Project Start
2000-09-01
Project End
2001-08-31
Budget Start
Budget End
Support Year
9
Fiscal Year
2000
Total Cost
$287,783
Indirect Cost
Name
Temple University
Department
Type
DUNS #
City
Philadelphia
State
PA
Country
United States
Zip Code
19122
Rom, Slava; Rom, Inna; Passiatore, Giovanni et al. (2010) CCL8/MCP-2 is a target for mir-146a in HIV-1-infected human microglial cells. FASEB J 24:2292-300
PiƱa-Oviedo, Sergio; Khalili, Kamel; Del Valle, Luis (2009) Hypoxia inducible factor-1 alpha activation of the JCV promoter: role in the pathogenesis of progressive multifocal leukoencephalopathy. Acta Neuropathol 118:235-47
Sariyer, Ilker K; Safak, Mahmut; Gordon, Jennifer et al. (2009) Generation and characterization of JCV permissive hybrid cell lines. J Virol Methods 159:122-6
White, Martyn K; Johnson, Edward M; Khalili, Kamel (2009) Multiple roles for Puralpha in cellular and viral regulation. Cell Cycle 8:1-7
Del Valle, Luis; White, Martyn K; Khalili, Kamel (2008) Potential mechanisms of the human polyomavirus JC in neural oncogenesis. J Neuropathol Exp Neurol 67:729-40
Mukerjee, Ruma; Deshmane, Satish L; Fan, Shongshan et al. (2008) Involvement of the p53 and p73 transcription factors in neuroAIDS. Cell Cycle 7:2682-90
Fischer-Smith, Tracy; Bell, Christie; Croul, Sidney et al. (2008) Monocyte/macrophage trafficking in acquired immunodeficiency syndrome encephalitis: lessons from human and nonhuman primate studies. J Neurovirol 14:318-26
Khalili, Kamel; Sariyer, Ilker Kudret; Safak, Mahmut (2008) Small tumor antigen of polyomaviruses: role in viral life cycle and cell transformation. J Cell Physiol 215:309-19
Kaminski, Rafal; Darbinyan, Armine; Merabova, Nana et al. (2008) Protective role of Puralpha to cisplatin. Cancer Biol Ther 7:1926-35
Perez-Liz, Georgina; Del Valle, Luis; Gentilella, Antonio et al. (2008) Detection of JC virus DNA fragments but not proteins in normal brain tissue. Ann Neurol 64:379-87

Showing the most recent 10 out of 34 publications